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Abstract To examine the possible involvement of a redox
regulating mechanism in the pathogenesis of immune-mediated
myocarditis, myocarditis was induced by immunization of
porcine cardiac myosin in rats and immunohistochemistry and
Western blot for thioredoxin (TRX) were performed. Immuno-
histochemistry for 8-hydroxy-2P-deoxyguanosine (8-OHdG) and
nuclear factor kappa-B (NF-UB) was also performed. TRX was
upregulated in the acute stage, but not in the chronic stage, and
the expression was correlated with the severity of the disease.
Damaged myocytes were strongly immunostained for 8-OHdG
and NF-UB. Thus, TRX may be specifically induced by acute
inflammatory stimuli, and the development of acute immune-
mediated myocarditis may be regulated by the cellular redox
state via TRX.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Myocarditis is an important cause of heart failure among
adolescents and young adults. Viral myocarditis frequently
precedes the development of dilated cardiomyopathy (DCM)
and is considered as a cause of DCM. Some cases of DCM
may be mediated by autoimmune responses to cardiac anti-
gens. At present, we have two animal models of myocarditis
to analyze the pathogenetic mechanisms responsible for im-
mune or autoimmune mechanisms. One is elicited by cardio-
tropic virus infection in mice and the other by immunization
of cardiac myosin in rodents [1,2]. The myosin immunization
model in rats mimics human fulminant myocarditis in the
acute phase and human DCM in the chronic phase [2,3].
Accordingly, this model is particularly suitable for studying
the immunopathology of in£ammatory heart diseases [2,3].
Adult T cell leukemia-derived factor was originally de¢ned
as an interleukin-2 (IL-2) receptor K-chain inducer in human
lymphotropic virus-1-transformed cells and is identical to thi-
oredoxin (TRX) [4,5]. TRX is a small multifunctional protein
which contains a redox-active disul¢de/dithiol within the con-
served active site sequence: -Cys-Gly-Pro-Cys [6]. TRX has
various important biological activities for both intra- and ex-
tracellular components. For example, TRX is stress-inducible
which protects cells from various types of stresses, e.g. viral
infection, exposure to ultraviolet (UV) light, X-ray irradiation
and hydrogen peroxide [7,8]. Moreover, TRX is a scavenger
of reactive oxygen intermediates (ROIs) and overexpression of
TRX in transgenic mice showed a protective function against
postischemic reperfusion injury in brain in vivo [9]. In myo-
carditis, ROIs are able to induce severe cardiovascular dys-
function and it was reported that oxygen free radicals may be
involved in the pathogenesis and development of coxsackievi-
rus B3 myocarditis and that appropriate dosages of superox-
ide dismutase have a therapeutic potential for myocarditis
[10,11]. However, it has not been reported whether myocardi-
tis is controlled by the redox regulatory protein, TRX. To
examine the cellular redox regulation in immune-mediated
myocarditis, giant cell myocarditis was induced by the immu-
nization of porcine cardiac myosin in rats. The role of the
cellular redox state in the development of immune-mediated
myocarditis was discussed.
2. Materials and methods
2.1. Antigen preparation and immunization
Autoimmune myocarditis was induced as previously described [2].
Porcine cardiac myosin (Sigma, M0531) was dissolved in phosphate
bu¡ered saline (PBS) at a concentration of 2 mg/ml. Six- to 7-week-
old Lewis rats (Shimizu Laboratory Supplies Co., Japan) were in-
jected subcutaneously in their foot pads with 0.1 ml of myosin (1
mg/ml) mixed with an equal volume of Freund’s complete adjuvant
(FCA) supplemented with Mycobacterium tuberculosis H37Ra (Difco,
3113-60) on days 1 and 7. Rats were killed serially on days 17 (n = 8),
21 (n = 14), 24 (n = 10) and 54 (n = 6) under ether anesthesia and were
processed for the immunohistochemical study and Western blotting
analysis. Littermate controls (n = 5) were injected with FCA alone and
were killed on day 21. After macroscopic examination, the ventricles
were ¢xed in 10% formalin, transversely sliced, embedded in para⁄n
and stained with hematoxylin and eosin. Tissue preparations were
examined with a microscope for the degree of myocardial damage
and the in¢ltration of in£ammatory cells.
2.2. Immunohistochemistry
For the analysis of TRX and nuclear factor kappa-B (NF-UB), we
used the immunoperoxidase technique [12]. Brie£y, after para⁄n sec-
tions of the heart were depara⁄nized and autoclaved for 10 min at
121‡C in 10 mmol/l citrate bu¡er (pH 6.0), endogenous peroxidase
activity was inactivated with 3% H2O2 for 10 min. The primary anti-
body (rabbit anti-mouse TRX antibody [12]; rabbit anti-human NF-
UB p65 antibody, Santa Cruz, C-20) or normal rabbit serum was
added and incubated overnight. It was reported that the rabbit anti-
mouse TRX antibody crossreacts on rats [12]. The rabbit anti-human
NF-UB p65 antibody crossreacts on humans and rats [13]. Biotinyl-
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Fig. 1. Histopathology and immunohistochemistry for TRX in immune-mediated myocarditis. A: Histology of the heart immunized with FCA
on day 21. The myocardium was intact. B: Histology of the heart immunized with myosin on day 21. Marked cellular in¢ltrations in the in-
£ammatory focus were observed. Moreover, multinuclear giant cells were observed (arrows). C: Histology of the heart immunized with myosin
on day 54. Myocarditis was almost healed and the area of myocardial necrosis was replaced by prominent ¢brous tissue. D: Immunohisto-
chemistry for TRX in the heart immunized with FCA on day 21. Marginal or trivial TRX immunoreactivity was observed. E: Immunohisto-
chemistry for TRX in the heart immunized with myosin on day 21. Strong TRX immunoreactivity was observed in both in¢ltrating in£amma-
tory cells in the in£ammatory focus (arrows) and damaged myocytes in the perinecrotic lesion (arrow head). F: Immunohistochemistry for
TRX in the heart immunized with myosin on day 54. TRX was slightly stained in myoctyes and was not stained in ¢brous tissue (arrow). A^
C: Hematoxylin and eosin staining. D^F: Immunohistochemical staining for TRX and counterstaining with hematoxylin. Magni¢cation, U180.
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ated and a⁄nity puri¢ed goat anti-rabbit immunoglobulin G (IgG)
(Dako) was used as the secondary antibody and incubated for 30 min.
Normal goat serum was added for the inhibition of non-speci¢c bind-
ing of a secondary antibody. An avidin^biotin complex was sequen-
tially added for 5 min incubation with the substrate 0.1% 3P,3P-di-
aminobenzidine at room temperature, followed by hematoxylin
nuclear counterstaining.
For the analysis of 8-hydroxy-2P-deoxyguanosine (8-OHdG), we
used the alkaline-phosphatase technique [14]. 8-OHdG was an estab-
lished marker for oxidative stress [14]. After depara⁄nization, the
primary antibody (Japan Institute for the Control of Aging, Fukuroi,
Shizuoka, Japan) or normal mouse serum was added and incubated
overnight. Biotin-labelled rabbit anti-mouse IgG (Dako) was used as
the second antibody for 40 min, followed by an avidin^biotin^alkaline
phosphatase complex (Vector). Counterstaining was not performed.
2.3. Western blot
The hearts were homogenized and then lysed for 30 min with 5 ml
of a lysis bu¡er (0.5% Nonidet P-40, 10 mmol/l Tris^HCl (pH 7.5),
150 mmol/l NaCl, 1 mmol/l phenylmethylsulfonyl £uoride and
5 mmol/l aprotinin) on ice. The extracts were cleared by centrifuga-
tion. Equal amounts of protein of the supernatant (8 Wg protein/lane),
estimated by the Bradford method using a protein assay (Bio-Rad),
were electrophoresed on a 15% sodium dodecyl sulfate^polyacryl-
amide gel and sequentially electrophoretically transferred to a poly-
vinylidene di£uoride microporous membrane (Millipore). After block-
ing with 5% bovine serum albumin in PBS containing 0.05% Tween 20
at 4‡C overnight, the membrane was incubated with the primary anti-
body (rabbit anti-mouse TRX antibody) and then with the peroxi-
dase-linked secondary antibody (Amersham Life Science). Chemilu-
minescence was detected with an ECL Western blot detection kit
(Amersham Pharmacia Biotech) and semiquantitatively analyzed us-
ing the NIH Image system.
3. Results
3.1. Histopathology
Immune-mediated giant cell myocarditis was induced in all
the rats immunized with porcine cardiac myosin. No evidence
of myocarditis was shown in the rats immunized with FCA
alone (Fig. 1A). In rats immunized with myosin, the hearts
showed mild and focal discolored myocarditis and a few in-
¢ltrating in£ammatory cells were observed on day 17. On
days 21 and 24, some of the hearts showed severe and di¡use
discolored myocarditis with massive pericardial e¡usion. In
in£ammatory foci, extensive injury of myocytes with various
kinds of in£ammatory changes, such as fragments of necrotic
myocardial ¢bers, mononuclear cells, polymorphonuclear neu-
trophils, eosinophils and multinucleated giant cells, was ob-
served (Fig. 1B). On day 54, active in£ammatory lesions were
healed and some cardiomyocytes showed degeneration. The
area of myocardial necrosis was replaced by prominent ¢-
brous tissue (Fig. 1C).
3.2. Immunohistochemistry and Western blot for TRX
Immunohistochemistry was performed to determine the his-
tological localization of TRX in the heart of immune-medi-
ated myocarditis. A control specimen with FCA alone (intact
heart) showed the trivial immunoreactivity for TRX (Fig.
1D). TRX was strongly stained in both in¢ltrating in£amma-
tory cells in the necrotic areas and damaged myocytes in the
perinecrotic lesions on day 21 (Fig. 1E). TRX was slightly
stained in myoctyes but not in ¢brous tissue on day 56 (Fig.
1F). Immunohistochemistry for TRX was observed in neither
the control intact heart nor the myocarditis specimen when
the primary antibody was omitted (data not shown). To de-
termine the level and stage of TRX induction in myocarditis,
the Western blot and semiquantitative analyses using the NIH
Image system for TRX was performed. The Western blot with
anti-mouse TRX antibody (Fig. 2) showed that levels of TRX
were higher in the rats with myosin immunization than in the
rats with FCA alone on day 21. Moreover, the expressions of
TRX were more increased in the rats with severe myocarditis
than in the rats with mild myocarditis. The expression of TRX
was decreased in the rats immunized with cardiac myosin on
day 54, compared with that on day 21. The data suggest that
the expression was correlated with the severity of the disease
and that TRX was upregulated not in the chronic stage but in
the acute immune-mediated stage. The rabbit anti-mouse
TRX antibody reacted on both smooth muscle cells (Fig.
2A, lane i) and myocytes (Fig. 2A, lanes b^h) in rats.
3.3. Immunohistochemistry of 8-OHdG and NF-UB
Immunohistochemistry for 8-OHdG was carried out to in-
vestigate whether ROIs were produced in immune-mediated
myocarditis. Myocytes of the control specimen with FCA im-
munization (intact heart) showed trivial nuclear immunostain-
ing (Fig. 3A). On day 21, 8-OHdG was strongly stained in the
nuclei of both in¢ltrating cells and myocytes in the perine-
crotic lesions (Fig. 3B). On day 56, weak nuclear staining
was observed in the nuclei of ¢broblasts and myocytes around
¢brous tissue (Fig. 3C). No nuclear staining was seen in the
specimen of myocarditis when the primary antibody was omit-
ted (data not shown).
Fig. 2. Western blot analysis for TRX. A: Representative Western
blot is shown. Lane a, recombinant TRX; lanes b and c, lysates
from two di¡erent hearts immunized with FCA on day 21; lanes d
and e, lysates from two di¡erent hearts immunized with myosin on
day 21 (mild myocarditis) ; lanes f and g, lysates from two di¡erent
hearts immunized with myosin on day 21 (severe myocarditis) ; lane
h, lysate from the hearts immunized with myosin on day 54; lane i,
lysate from rat smooth muscle cells. Protein of 8 Wg per lane was
loaded except for lane a (recombinant TRX, 100 ng). B: Densito-
metric band intensities were shown. The level of TRX was higher in
the rats with myocarditis induced by myosin immunization than in
normal rats immunized with FCA alone. Moreover, the expression
of TRX was more intense in the rats with severe myocarditis than
in the rats with mild myocarditis. The level of TRX was decreased
in the rats immunized with cardiac myosin on day 54, compared
with on day 21. Levels of TRX in normal rats immunized with
FCA alone were normalized to 100% in each experiment and rela-
tive levels of TRX were expressed. Data are mean þ S.E.M. of four
independent experiments.
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Immunohistochemistry for NF-UB showed that the myo-
cytes in the perinecrotic lesions were strongly stained (Fig.
4B), compared with those of the control specimens with
FCA alone (intact heart) (Fig. 4A). No staining was seen in
the specimen of myocarditis when the primary antibody was
omitted (data not shown). The results suggest that ROIs may
be involved in the development of myocardial damage in im-
mune-mediated myocarditis. Taken together, the upregulation
of TRX may be a reaction to oxidative stress possibly pro-
duced by in¢ltrating cells in the myocardium.
4. Discussion
Our study provides the ¢rst in vivo evidence that the redox
regulatory protein, TRX, was upregulated in immune-medi-
ated giant cell myocarditis and that it is upregulated in the
acute immune-mediated stage, but not in the chronic stage.
TRX per se and the cellular redox state controlled by TRX
may play an important role in the pathogenesis and develop-
ment of the disease.
8-OHdG, one of the major DNA base-modi¢ed products, is
induced either by hydroxyl radical, singlet oxygen or photo-
Fig. 3. Immunohistochemistry for 8-OHdG in immune-mediated
myocarditis. A: Immunohistochemistry for 8-OHdG in the intact
heart immunized with FCA alone on day 21. In control intact
heart, slight or no nuclear staining was observed. B: Immunohisto-
chemistry for 8-OHdG in the heart immunized with myosin on day
21. Strong nuclear staining was observed in both in¢ltrating in£am-
matory cells in the in£ammatory focus (arrow) and myocytes in the
perinecrotic lesions (arrow heads). C: Immunohistochemistry for 8-
OHdG in the heart immunized with myosin on day 54. Weak nu-
clear staining was observed in nuclei of ¢broblast (arrow) and myo-
cytes around ¢brous tissue (arrow head). Counterstaining with hem-
atoxylin was not done. Magni¢cation, U188.
Fig. 4. Immunohistochemistry for NF-UB in immune-mediated myo-
carditis. A: Immunohistochemistry for NF-UB p65 in the intact
heart immunized with FCA alone on day 21. Myocytes were slightly
stained. B: Immunohistochemistry for NF-UB p65 in the diseased
heart immunized with myosin on day 21. Myocytes in the perine-
crotic lesions were strongly stained (arrows). Counterstaining with
hematoxylin was performed. Magni¢cation, U200.
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dynamic action and is known to be mutagenic by pairing with
adenine as well as cytosine, leading to G:C to T:A transver-
sion at DNA replication [15,16]. Accordingly, 8-OHdG is an
established marker for oxidative stress. In the present study,
8-OHdG was expressed in the necrotic areas and perinecrotic
lesions of myocarditis. It was already reported that TRX was
induced by ROIs in the mouse kidney [17]. Thus, taken to-
gether, the results of the present study suggest that enhanced
TRX expression may be induced by ROIs produced by in¢l-
trating in£ammatory cells in acute immune-mediated myocar-
ditis.
It was reported that TRX has the function of redox regu-
lation of the transcription factors such as NF-UB or activator
protein-1 [18]. In the present study, the expression of NF-UB
was enhanced in the perinecrotic lesions of immune-mediated
myocarditis. As TRX is known to regulate NF-UB activation
via its thiol redox control [19], enhanced TRX expression may
respond to the corresponding overexpression of NF-UB in the
cytoplasm. It was reported that ROIs induce translocation of
TRX from the cytoplasm into the nucleus and that TRX in
the nucleus enhances NF-UB transcriptional activities in its
ability to bind to DNA [19]. There is accumulating evidence
that the activation of NF-UB mediates cytoprotective signal
transductions [20]. Thus, TRX per se may have a protective
role against the progressive myocardial damage in acute im-
mune-mediated myocarditis through the activation of NF-UB.
An appropriate dosage of TRX may have therapeutic poten-
tial for the treatment of the acute stage of myocarditis.
We analyzed TRX expression in spontaneously hyperten-
sive rats (SHR) in another set of experiments. SHR is a ge-
netic model of chronic overload with a lifetime elevated sys-
tolic blood pressure and established left ventricular
hypertrophy and myocardial ¢brosis [21,22]. In 4-week-old
SHR, hypertension begins to develop and in 14-week-old
SHR, with early hypertensive heart disease, left ventricular
hypertrophy and myocardial ¢brosis is observed [21,22]. We
found that the immunoreactivity of TRX in 14-week-old SHR
was equal to that in their normotensive genetic control age-
matched Wistar^Kyoto rats. That is, TRX was not induced
by the chronic hypertensive stimuli (data not shown). Taking
this together with the result that TRX was reduced in the
chronic or healed stage of myocarditis, TRX seemed to be
speci¢cally induced by the acute in£ammatory stimuli.
In summary, TRX was upregulated in acute immune-medi-
ated giant cell myocarditis. Our ¢ndings suggest that the de-
velopment of acute immune-mediated myocarditis may be
regulated by the cellular redox state via TRX.
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